Country: United States
Language: English
Source: NLM (National Library of Medicine)
DEXPANTHENOL (UNII: 1O6C93RI7Z) (DEXPANTHENOL - UNII:1O6C93RI7Z)
MWI
INTRAMUSCULAR
PRESCRIPTION
COMPOSITION: Each mL contains: Dexpanthenol………………………………..250 mg Benzyl Alcohol…………………………...…1% w/v Water for Injection……………….…………….. q.s. Acetic Acid, Glacial, USP………….. to adjust pH INDICATIONS: For use as a nutritional source of dexpanthenol. TAKE TIME OBSERVE LABEL DIRECTIONS CONTRAINDICATIONS: In therapy of colic resulting from the administration of cholinergic type anthelmintics.
unapproved drug other
DEXPANTHENOL - DEXPANTHENOL INJECTION, SOLUTION MWI _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- DEXPANTHENOL NDC 13985-535-10 VETOne D-PANTHENOL INJECTION Keep out of reach of children. For animal use only. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Rev. 6/12 V1 510233 Net Contents: 100 mL Distributed by: MWI Boise, ID 83705 (888) 694-8381 www.vetone.net COMPOSITION: Each mL contains: Dexpanthenol………………………………..250 mg Benzyl Alcohol…………………………...…1% w/v Water for Injection……………….…………….. q.s. Acetic Acid, Glacial, USP………….. to adjust pH INDICATIONS: For use as a nutritional source of dexpanthenol. TAKE TIME OBSERVE LABEL DIRECTIONS DOSAGE AND ADMINISTRATION: DOGS and CATS: 25 mg per 5 lbs. body weight intramuscularly. HORSES: Initial dose 10 cc intravenously or intramuscularly. PRECAUTION: Following the administration of succinylcholine chloride, a one-hour waiting period is advisable before initiation of dexpanthenol therapy. CONTRAINDICATIONS: In therapy of colic resulting from the administration of cholinergic type anthelmintics. DEXPANTHENOL dexpanthenol injection, solution PRODUCT INFORMATION PRODUCT T YPE PRESCRIPTION ANIMAL DRUG ITE M CODE (SOURCE ) NDC:139 8 5-535 ROUTE OF ADMINISTRATION INTRAMUSCULAR, INTRAVENOUS ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH DEXPANTHENO L (UNII: 1O6 C9 3RI7Z) (DEXPANTHENOL - UNII:1O6 C9 3RI7Z) DEXPANTHENOL 250 mg in 1 mL PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:139 8 5-535-10 10 0 mL in 1 VIAL, MULTI-DOSE MWI MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 0 4/0 1/20 0 8 LABELER - MWI (019926120) Revised: 12/2017 Read the complete document